Versant Venture Management
Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GLUE, CRSP, CTNM, SKYE, RPTX, and represent 93.90% of Versant Venture Management's stock portfolio.
- Added to shares of these 2 stocks: GLUE (+$39M), TPST.
- Started 2 new stock positions in TPST, GLUE.
- Reduced shares in these 1 stock: GRTSQ.
- Sold out of its position in GRTSQ.
- Versant Venture Management was a net buyer of stock by $40M.
- Versant Venture Management has $87M in assets under management (AUM), dropping by 36.45%.
- Central Index Key (CIK): 0001560009
Tip: Access up to 7 years of quarterly data
Positions held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 45.2 | $39M | NEW | 5.7M | 6.94 |
|
| CRISPR Therapeutics Common Shares (CRSP) | 22.6 | $20M | 499k | 39.36 |
|
|
| Contineum Therapeutics Common Stock (CTNM) | 15.5 | $14M | 918k | 14.65 |
|
|
| Skye Bioscience Common Stock (SKYE) | 6.5 | $5.7M | 2.0M | 2.83 |
|
|
| Repare Therapeutics Common Stock (RPTX) | 4.0 | $3.5M | 2.6M | 1.31 |
|
|
| Tempest Therapeutics Common Stock (TPST) | 3.4 | $2.9M | NEW | 3.5M | 0.83 |
|
| Adverum Biotechnologies Common Stock | 2.7 | $2.4M | 507k | 4.67 |
|
Past Filings by Versant Venture Management
SEC 13F filings are viewable for Versant Venture Management going back to 2014
- Versant Venture Management 2024 Q4 filed Feb. 12, 2025
- Versant Venture Management 2024 Q3 filed Nov. 8, 2024
- Versant Venture Management 2024 Q2 filed Aug. 7, 2024
- Versant Venture Management 2024 Q1 filed May 3, 2024
- Versant Venture Management 2023 Q4 filed Feb. 8, 2024
- Versant Venture Management 2023 Q3 filed Nov. 3, 2023
- Versant Venture Management 2023 Q2 filed Aug. 9, 2023
- Versant Venture Management 2023 Q1 filed May 11, 2023
- Versant Venture Management 2022 Q4 filed Feb. 9, 2023
- Versant Venture Management 2022 Q3 filed Nov. 10, 2022
- Versant Venture Management 2022 Q2 filed Aug. 11, 2022
- Versant Venture Management 2022 Q1 filed May 10, 2022
- Versant Venture Management 2021 Q4 filed Feb. 11, 2022
- Versant Venture Management 2021 Q3 filed Nov. 12, 2021
- Versant Venture Management 2021 Q2 filed Aug. 12, 2021
- Versant Venture Management 2021 Q1 filed May 7, 2021